Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast Implant-Associated Malignancies: Current Recommendations for Workup and Management.

Plastic and reconstructive surgery·2026
Same author

Editorial Expression of Concern: A FADD-dependent innate immune mechanism in mammalian cells.

Nature·2026
Same author

Molecular Classification of Central Nervous System Tumors in Developing Countries: Challenges, Opportunities, and Feasibility in a Pathology Reference Laboratory.

Archives of pathology & laboratory medicine·2026
Same author

Primate resident memory T cells activate humoral and stromal immunity.

Immunity·2025
Same author

Sinonasal Tract Osteochondromyxoma: An Underrecognized Tumor Easily Mistaken for Nasal Chondromesenchymal Hamartoma.

Head and neck pathology·2025
Same author

Distinctive genomic features of hydroa vacciniforme lymphoproliferative disorder in Latin American patients: A multicenter multi-omics study.

Journal of the American Academy of Dermatology·2025

Related Experiment Video

Updated: Jun 4, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Pediatric lymphomas in Brazil.

Gabriela Gualco1, Claudete E Klumb, Glen N Barber

  • 1Consultoria em Patologia, Botucatu, São Paulo, Brazil.

Clinics (Sao Paulo, Brazil)
|February 23, 2011
PubMed
Summary
This summary is machine-generated.

This study analyzed 1301 pediatric lymphomas in Brazil, finding Non-Hodgkin lymphomas (NHL) were most common. Geographic and age distributions varied, with specific subtypes like Burkitt lymphoma prevalent in NHL cases.

More Related Videos

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

Related Experiment Videos

Last Updated: Jun 4, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Pathology

Background:

  • Lymphomas are a significant group of cancers affecting children and adolescents.
  • Understanding the epidemiological and pathological characteristics of pediatric lymphomas is crucial for diagnosis and treatment.
  • Brazil, with its diverse population and geography, presents a unique setting for studying these characteristics.

Purpose of the Study:

  • To describe the clinical pathological characteristics of a large cohort of pediatric and adolescent lymphomas in Brazil.
  • To analyze the distribution of lymphoma subtypes, age groups, and geographic regions.
  • To provide insights into the epidemiology of pediatric lymphomas in a South American population.

Main Methods:

  • Retrospective analysis of 1301 diagnosed pediatric lymphoma cases over a 10-year period.
  • Data collection included patient demographics, geographic origin, age distribution, and histopathological subtypes.
  • Classification followed established criteria for Non-Hodgkin lymphomas and Hodgkin lymphomas.

Main Results:

  • Non-Hodgkin lymphomas (NHL) constituted 68% of cases, with precursor (36%) and mature (64%) cell origins. Mature B-cell lymphomas were predominant (81%), with Burkitt lymphoma (65%) being the most common subtype.
  • Hodgkin lymphomas (HL) accounted for 32% of cases, primarily classical type (87%). Nodular lymphocyte predominant type was more frequent than in other series.
  • Geographic distribution showed higher incidence in the Southeast (38.4%) and Northeast (28.7%) regions. Age distribution peaked in the 15-18 year olds (33%).

Conclusions:

  • The findings highlight the epidemiological landscape of pediatric lymphomas in Brazil, with a notable prevalence of NHL, particularly Burkitt lymphoma.
  • Regional variations in incidence and subtype distribution may be influenced by socioeconomic and environmental factors across Brazil.
  • This comprehensive series provides valuable data for understanding and managing pediatric lymphomas in diverse populations.